Lieff Cabraser partner Paulina do Amaral will be speaking at the American Association for Justice (AAJ) upcoming opioid litigation conference in Washington, D.C. on September 13th and 14th. The number of prescription opioids sold in America over the last few decades has quadrupled, resulting in tens of thousands of deaths per year by prescription opioid overdose. The most recent analysis indicates 60,000 Americans died in 2016 alone from opioid addiction-related injuries.
Many surviving victims are filing lawsuits against medical professionals and drug companies for their role in this nationwide opioid epidemic. Learn more about the role big pharma and the medical community has played, pending lawsuits and underlying legal theories, and what you can do to help clients and communities who have become victims of the opioid epidemic.
Entitled “Rapid Response: Opioid Litigation Seminar,” the program will cover a wide range of topics, including Multidistrict Litigation Approaches, RICO, Case Organization, Accountability, the DEA, and Statues of Limitation issues, among many others.
About the American Association for Justice
The American Association for Justice provides trial attorneys with information, professional support and a nationwide network that enables them to most effectively and expertly represent clients. The mission of the American Association for Justice is to promote a fair and effective justice system—and to support the work of attorneys in their efforts to ensure that any person who is injured by the misconduct or negligence of others can obtain justice in America’s courtrooms, even when taking on the most powerful interests. Visit the AAJ online at justice.org.
About Paulina do Amaral
Paulina do Amaral has dedicated her career to achieving justice for individuals injured by dangerous and defective products and other corporate wrongdoing both in the United States and abroad. As a partner in Lieff Cabraser’s New York office, she represents classes, groups, and individuals in complex, multi-party litigation in state and federal courts and in multidistrict litigation throughout the U.S. She currently represents women in lawsuits over uterine cancer injuries allegedly caused by long-term use of talc products, infant birth defects that mothers claim relate to their use of the anti-nausea drug Zofran during pregnancy, and serious complications and injuries tied to the implantation of allegedly defective surgical mesh.